Abiogen Pharma is a Pisa-based Italian pharmaceutical company and strategic corporate investor focused on biotechnology and pharmaceuticals. Its investor profile is most relevant to therapeutics companies seeking a pharma strategic backer, with supported early-stage investment activity in the United States. The company’s operating focus spans areas such as bone metabolism, vitamin D deficiency, pain, dermatology, respiratory and diabetology, making it a targeted fit for founders where clinical or pharmaceutical-sector expertise is valuable.